Drug container enclosure with RFID label

Abstract

This disclosure relates, in general, to drug delivery devices such as auto-injectors or injectors, and more particularly to drug container enclosures (10) for housing drug containers.

Description

Technical Field

[0001] The present disclosure generally relates to drug delivery devices, and more particularly to a drug container enclosure for housing a drug container.

Background Art

[0002] Many medical conditions require injections. In recent years, there are various injection devices, including various types of pen injectors, autoinjectors, and infusion devices for large-volume infusion. Many of these devices have enabled significant improvements in the management of many medical conditions, but there are still various limitations in the current technology. Among these, in particular, there are difficulties faced by patients who need them frequently. When considering these problems, the applicant recognizes that various developments can be made to improve the currently commercially available drug delivery devices, for example, with respect to complex drug scenarios where it is important that the drugs are administered in a predetermined order, as described in more detail below. The drugs can be related to advanced treatments in a home environment, for example, related to oncology. The drugs and the order are determined by a physician or healthcare provider who submits a prescription to a pharmacy. The pharmacist prepares and packages the drugs for the patient. However, in the current procedure, the patient needs to identify and administer the drugs correctly.

Summary of the Invention

[0003] An object of the present disclosure is to provide a drug container enclosure for housing a drug container that solves or at least alleviates the problems of the prior art.

[0004] According to a first aspect of the present disclosure, there is provided a drug container enclosure for housing a drug container, the drug container enclosure comprising a designated portion including a series of marks for indicating the placement of an RFID label, and an RFID label attached to the designated portion according to the series of marks, the RFID label comprising a processing circuit and a circuit loop each having a circuit path aligned with one of each of the marks of the designated portion, and by passing through the marks, each circuit loop is broken.

[0005] Embodiments of this disclosure advantageously provide an information system for medications that can be entered by manually punching a mark. This frees users, for example, patients, from relying on written instructions. Instead, a pharmacist or drug provider can directly enter information onto an RFID label on the drug container enclosure.

[0006] Alternatives to electronically write sequence information directly to RFID chips require pharmacies to invest in hardware and software capabilities. The high investment costs for such systems and their verification make it difficult to encourage the use of specific devices.

[0007] Furthermore, the markings on the drug container enclosure facilitate the placement of RFID labels. Breaking each circuit loop is performed with less effort due to the design and structure of the markings.

[0008] In this disclosure, when the term “distal direction” is used, it refers to the direction away from the dose delivery site during use of the drug delivery device. When the term “distal portion / distal end” is used, it refers to the part / end of the delivery device, or part / end of its component, that is furthest away from the dose delivery site during use of the drug delivery device. Correspondingly, when the term “proximal direction” is used, it refers to the direction toward the dose delivery site during use of the drug delivery device. When the term “proximal portion / proximal end” is used, it refers to the part / end of the delivery device, or part / end of its component, that is furthest away from the dose delivery site during use of the drug delivery device.

[0009] Furthermore, the terms “longitudinal,” “longitudinally,” “axially,” or “axial” refer to the direction extending from the proximal end to the distal end, typically along the device or its components, in the direction of the longest extension of the device and / or components.

[0010] Similarly, the terms "transverse," "transversal," and "transversally" refer to a direction that is generally perpendicular to the longitudinal direction.

[0011] Furthermore, the terms “circumference,” “circumferential,” and “circumferentially” refer to the circumferential or circumferential direction 301 with respect to the axis 102, typically the central axis extending in the longest direction of the device and / or component. Similarly, “radial” or “radially” refers to the direction 302 extending radially with respect to the axis, and “rotation,” “rotational,” and “rotationally” refer to rotation with respect to the axis.

[0012] According to one embodiment, drug information may be readable from the RFID label, and the drug information depends on which of the circuit loops is broken. Advantageously, the RFID label may contain predetermined information, such as a unique identifier and other information, which can be written to the RFID label's memory. This provides the ability to manipulate the RFID label without requiring a validated RFID writer system to input information into the RFID label. Such RFID writer systems are expensive and cumbersome to implement.

[0013] According to one embodiment, the RFID label may include a visual label to guide the pharmacist to the correct mark for entering the desired medication information. Advantageously, the visual label assists the user in entering the correct mark for entering the intended medication information. The visual label may be printed on a separate layer of the RFID label attached to a circuit layer containing a circuit loop.

[0014] In some implementations, labels or tabs may be added on top of the RFID label and the visual label to eliminate the possibility of them penetrating and breaking the remaining circuit loop.

[0015] According to one embodiment, drug information may include the order in which the current drug container is located within the current dosing sequence. The order may be, for example, 1st, 2nd, 3rd, etc., if the current drug container is the drug in the current sequence. Thus, the user is helped to inject or administer the drug in the current order. The drug delivery device can read the RFID label to check whether the correct drug container enclosure is provided.

[0016] According to one embodiment, the drug information may, advantageously, include the total number of injections to be administered in the current drug administration sequence.

[0017] According to one embodiment, the mark may include a series of holes or voids in the drug container enclosure. Having holes or voids in the material of the drug container enclosure reduces the amount of force required to penetrate the mark. The tool used to penetrate the mark thereby enters or punctures the holes or voids.

[0018] According to one embodiment, a series of marks may include a series of vulnerable points in the drug container enclosure. These vulnerable points may be made of a different material from the rest of the drug container enclosure, such as voids or holes filled with a more brittle material that is more easily penetrated than the bulk material of the drug container enclosure. Another embodiment may include a label tab with a peelable circuit.

[0019] According to one embodiment, the RFID label may be attached to the drug container enclosure by adhesive. That is, the RFID label may be a flexible multilayer label that is adhered to the drug container enclosure in a designated area.

[0020] According to one embodiment, the drug container enclosure may be mounted within a drug delivery device equipped with an RFID reader.

[0021] According to a second aspect, a drug delivery device is provided which is configured to accept a drug container enclosure according to any one of the embodiments described herein, the drug delivery device comprising an RFID reader including a processing circuit, the RFID reader being configured to read drug information, compare the read drug information with drug information stored on the device, and provide the user with a display of the comparison via a user interface.

[0022] Further effects and features of the second aspect of this disclosure are largely similar to those described above in relation to the first aspect of this disclosure.

[0023] According to a third embodiment, an RFID label is provided that is configured to be attached to a drug container enclosure, the RFID label comprising a processing circuit and at least one circuit loop, the end of each circuit loop being electrically connected to the processing circuit, the circuit loop being configured to be broken by piercing the RFID label with an external tool for inputting drug information, the processing circuit being configured to detect whether the circuit loop is complete or broken.

[0024] According to one embodiment, the breaking of the circuit loop can provide drug information to the processing circuit.

[0025] According to one embodiment, the RFID label may include a visual label for guiding the user, i.e., the pharmacist, to enter the desired drug information through the correct position.

[0026] According to one embodiment, the drug information can include the order in which the current drug container has in the current dosing sequence. 1]

[0027] According to one embodiment, the drug information may include the total number of injections to be administered in the current dosing sequence.

[0028] The further effects and features of the second aspect of the present disclosure are mostly similar to those described above in relation to the first and second aspects of the present disclosure.

[0029] In general, all terms used in the claims should be construed according to their ordinary meanings in the relevant technical field, unless explicitly defined otherwise herein. All references to "a / an / the member, apparatus, component, means, etc." shall be construed, without limitation, as referring to at least one instance of the member, apparatus, component, means, etc., unless specifically specified otherwise.

Brief Description of the Drawings

[0030] Hereinafter, specific embodiments of the concept of the present invention will be described by way of example with reference to the accompanying drawings. [Figure 1A] It is a perspective view of a drug delivery device according to an embodiment of the present disclosure. [Figure 1B] It is a perspective view of a drug delivery device and a drug container enclosure according to an embodiment of the present disclosure. [Figure 2A] The main body of the drug container enclosure is illustrated according to an embodiment of the present disclosure. [Figure 2B] An embodiment of the present disclosure illustrates a drug container enclosure having an RFID label. [Figure 2C] An embodiment of the present disclosure illustrates a drug container enclosure having an RFID label and a visual label. [Figure 3] The signal levels read by the processing circuit according to the state of the circuit loop are illustrated. [Figure 4] This is an exploded view of a drug container enclosure according to an embodiment of the present disclosure. [Figure 5] This is an exploded view of a drug container enclosure according to an embodiment of the present disclosure. [Figure 6] A drug delivery device configured to accept a drug container enclosure is schematically illustrated. [Modes for carrying out the invention]

[0031] The concept of the present invention will be further described below with reference to the accompanying drawings illustrating exemplary embodiments. However, the concept of the present invention can be embodied in many different forms and should not be construed as being limited to the embodiments described herein. Rather, these embodiments are provided as examples so that this disclosure may be thorough and complete and so as to convey the scope of the concept of the present invention to those skilled in the art. Throughout this description, similar numbers refer to similar components.

[0032] Figure 1A shows an example of a drug delivery device 1, such as a self-injector, according to an embodiment of the present disclosure. The drug delivery device 1 is configured to dispense a drug from a drug container to the user at a dose delivery site via a drug delivery member such as a needle. The drug delivery device 1 extends from a proximal end 1a to a distal end 1b with respect to an axis 102.

[0033] The drug delivery device 1 includes a housing 3 having a window 4. The housing 3 has a proximal end 3a and a distal end 3b. A needle shield 6, configured to cover the needle, extends outward from the proximal end 3a of the housing 3.

[0034] The drug container is located inside the housing 3, and the drug is dispensed from there under the action of a spring-driven plunger.

[0035] Figure 1B shows another example of a drug delivery device 1, such as a self-injector, according to an embodiment of the present disclosure. The drug delivery device 100 is configured to dispense a drug from a drug container to a user at a dose delivery site via a drug delivery member, such as a needle 2. The drug delivery device 100 extends from a proximal end 1a to a distal end 1b with respect to an axis 102.

[0036] The drug delivery device 1 includes a housing 3 and is connectable to a drug container enclosure 4 having a proximal end 4a and a distal end 4b.

[0037] A drug container enclosure 4, which may be a disposable cassette, is connected in this example to an infusion set 7, which includes a flexible tube 8 connected at its proximal end 4a to a through-hole in the disposable cassette 4. A needle 2 is attached to the other end of the tube 8 via a pad 9. The infusion set 7 is optional in embodiments of the present disclosure.

[0038] The disposable cassette 4 is adapted to accommodate drug containers of various capacities, which may range from approximately 1 mL to approximately 10 mL.

[0039] The drug delivery device 1 includes an acceptance interface 11 configured to accept a disposable cassette and lock onto the proximal end 1a of the drug delivery device 1.

[0040] The drug container enclosure 4 is adapted to house a drug container that holds a drug.

[0041] Auto-injectors and other types of products for delivering drugs to users provide efficient means of administering medications. In the case of combined drug administration, a new level of complexity is added. In particular, user involvement increases to ensure that drugs are injected or administered in the correct order. The most common solution in modern technology is to communicate the drug delivery sequence to the user via verbal and / or written instructions and labels. However, this solution relies on the user correctly interpreting and executing the instructions.

[0042] This specification proposes drug container enclosures and RFID labels that at least partially mitigate the shortcomings of the prior art.

[0043] One advantage of the proposed solution is that it does not require patients to rely on instructions, for pharmacies to design an IT system with an API that remotely communicates drug types and sequences to drug delivery systems (from different manufacturers), or for staff to directly program the device system. The latter would require patients to send or bring the system to the pharmacy before each dosing round. The former would require the device system and the pharmacy backend to have reliable wired or wireless telecommunication.

[0044] Figure 2A schematically shows a drug container enclosure 10. The drug container enclosure 10 is adapted to house a drug container that holds a drug. The drug container enclosure 10 may be provided in various forms for holding the drug container, such as a box, a plastic container, or a disposable cassette 4 shown in Figure 1B.

[0045] The drug container enclosure 10 includes a designated portion 12 containing a series of marks 14 (only one of which is numbered) for indicating the placement of the RFID label. In this exemplary embodiment, the drug container enclosure 10 has six marks 14.

[0046] The mark 14 may include a series of holes or voids in the drug container enclosure 10. That is, pre-fabricated holes or voids in the bulk material of the drug container enclosure 10 may form the mark. The mark may further include a visual indication of the location of the holes in the voids.

[0047] In other embodiments, the series of marks 14 may include a series of vulnerable points in the drug container enclosure 10. These vulnerable points can be penetrated, for example, by the force with which a user, i.e., a pharmacist, stabs a pen into the marks with their hand.

[0048] Referring to Figure 2B, the drug container enclosure 10 further comprises an RFID label 16 attached to a designated portion 12 according to a series of marks 14. The RFID label comprises a processing circuit 18 and circuit loops 20, each having a circuit path aligned with one mark 14 on each of the designated portions 12. In Figure 2A, an enclosure 10 without the RFID label 16 is added to show how the circuit loops 20 are aligned with the marks 14.

[0049] The alignment between mark 14 and each circuit loop 20 is such that each circuit loop 20 is broken when mark 14 penetrates the layer of RFID label 16. Therefore, penetrating mark 14 breaks each circuit loop 20.

[0050] Figure 2C shows a drug container enclosure 10 having an RFID label 16, which also includes a visual label 22 to guide a user, such as a pharmacist, to the correct mark 14 for entering the desired drug information.

[0051] In this example, the label has, in the lower column, the order in which the current drug container is located in the current dosing sequence, and in the upper column, the total number of injections to be administered in the current dosing sequence. In other words, to program the processing circuit 18 with drug information, the pharmacist inputs the number of injections and the order in the injection sequence for each drug container by marking the correct marks 14 according to the label 22.

[0052] The drug container enclosure 10 can be attached to a drug delivery device equipped with an RFID reader. Drug information is readable from the RFID label 16, and the drug information is determined by which of the circuit loops 20 is broken.

[0053] When power is supplied, the processing circuit evaluates whether the circuit loop is complete or broken. Depending on whether the circuit loop is connected or not, i.e., whether it is complete or not, the processing circuit reads different resistances or voltages, and consequently yields different signals, i.e., high or low, or 1 or 0.

[0054] Figure 3 illustrates the signals read by the processing circuit 18 depending on the state of the circuit loop 20. Here, each of the loops, indicated by A to F, is associated with one piece of drug information. For example, circuit loops A, B, and C may refer to a total number of injections, for example, 1, 2, and 3, respectively. Furthermore, circuit loops E, F, and G may refer to the order in the sequence in which a particular drug is administered, i.e., the 1st, 2nd, or 3rd, respectively. If a circuit loop is broken, a high signal and digital 1 are registered; if the circuit loop is complete, a low signal and digital 0 are registered. In this particular example, when the processing circuit 18 reads the circuit loop 20, the drug information is that the total number of injections in the current sequence is 3, and the current drug is the 2nd drug in that sequence. When the RFID label 16 is read by the drug delivery device, this information is received and can be checked against previous injections to confirm that the correct drug is loaded into the drug delivery device in the current sequence.

[0055] Figure 4 is an exploded view of the drug container enclosure 10. The drug container enclosure includes a designated portion 12 on the body 25 of the drug container enclosure 10. The designated portion 12 may be provided with a series of marks 14 as gaps, holes, or weak points that can be penetrated by a pointed tool.

[0056] In another layer, the RFID label 16 is attached to the drug container enclosure body 25, for example, by adhesive. The RFID label 16 is attached to the bottom layer, a designated portion 12. The RFID label 16 comprises a processing circuit 18 and a circuit loop 20 electrically connected to the processing circuit 18. The circuit loop 20 reaches a mark 14 so that a portion of the circuit loop is aligned with the mark. The processing circuit 18 is configured to detect whether the circuit loop is complete or broken.

[0057] At the top layer, a visual label 22 is positioned as part of the RFID label, i.e., printed on the RFID label or as a separate layer attached to the RFID label 16. The label 22 guides the pharmacist to the correct location for entering the desired medication information. The label 22 typically contains written information for user instruction.

[0058] In Figure 4, the circuit loop 20 is shown as a planar circuit in a horizontal plane, i.e., a single plane parallel to the main plane of the RFID label 16. In other possible embodiments, the circuit loop may be a double planar circuit loop with vertical connections.

[0059] Figure 5 illustrates a possible sequence for using embodiments of the present disclosure. The drug container enclosure 10 is provided as described above. A user, typically a pharmacist, uses a pointed tool 27 to pierce the correct marks 14, based on which drug information they wish to input and guided by a visual label 22. The visual label 22 is on top, the marks 14 are on the bottom, and the RFID label is sandwiched between the marks 14 and the visual label 22.

[0060] In this case, the total number of containers is 2, and the current container 10 is the first in the sequence. By passing through mark 14, a circuit loop 20 is triggered that corresponds to the total number of containers being 2 and the current container 10 being the first in the sequence. The processing circuit 18 of the RFID label 16 can access the instruction that the given circuit loop corresponds to the given drug information.

[0061] Figure 6 illustrates a drug delivery device 30 configured to receive a drug container enclosure 10. The drug delivery device may be of various types and is not limited to auto-injectors, and may include an RFID reader 32 including a processing circuit 34 configured to read drug information from an RFID label 16.

[0062] Therefore, the processing circuit 34 reads the order in which the current container is located in the current drug administration sequence, and the total number of injections in the current sequence.

[0063] The processing circuit 34 can compare the read drug information with, for example, stored drug information related to a previously administered injection, or compare the unique identifier of the current container with a pre-stored ID related to the drug to be administered, thereby confirming that the same container has not been inserted twice.

[0064] The processing circuit 34 provides the user with a comparison display via the user interface 36. The user interface 36 may be, for example, an audio, visual, or haptic interface. Thus, the device 30 can read whether the inserted containers 10 are in the correct order with respect to the information given by the labels and compare it with data from previous injections that have been processed and stored locally within the device 30's system.

[0065] Embodiments of this disclosure can be applied to various drug delivery devices. In one possible embodiment, drug delivery may be via an autoinjector.

[0066] A drug delivery device (such as an auto-injector) may generally include a variety of other components. These may include, for example, a sensor unit that can recognize drug delivery events, such as when a needle is inserted into a pad attachment, when injection begins, and when the drug delivery operation is completed; a memory unit configured to store data recorded during the drug delivery operation; a connectivity unit configured to transmit the stored data directly to a smart device or network; a processing unit configured to control the entire system and process data before transmitting it; and / or a user interface unit configured to provide feedback to the patient, such as status LEDs, tactile feedback, and / or audio feedback.

[0067] When the drug delivery device is placed on the attachment site, sensors inside the pad recognize this event and are configured to provide feedback to the patient via tactile / visual or auditory elements.

[0068] Once drug delivery is complete, the sensor recognizes the event and is configured to provide feedback to the patient again. Furthermore, the collected data can be stored in a memory unit and transmitted to a smart device / network via a connectivity unit after the drug delivery event has finished.

[0069] The sensor can be a mechanical switch, a Hall effect sensor, an accelerometer, or a combination of these.

[0070] A mechanical switch, a Hall effect sensor, or an accelerometer can be used to detect when a needle has been inserted into the injection port.

[0071] Accelerometers can be used to detect drug delivery events.

[0072] Possible wireless communication methods include Bluetooth and cellular networks.

[0073] Bluetooth connectivity requires a smart device to transmit stored data over the network, and in the case of bidirectional connectivity, a pairing action is required between the pad and the smart device before the support pad can be used. However, this is a less expensive alternative and requires less space on the PCB. Unidirectional connectivity does not require pairing.

[0074] Cellular networks eliminate the need for any pairing process, can be used as plug-and-play devices, and require no prior setup, but they are expensive and require a lot of space on the PCB.

[0075] Depending on the product requirements, one of these two technologies can be used.

[0076] Such processing units or processing circuits may include logic circuits or control units, including a microprocessor, microcontroller, programmable digital signal processor, or other programmable device. Each processing circuit may further, or instead, include an application-specific integrated circuit, a programmable gate array or programmable array logic, a programmable logic device, or a digital signal processor. If the processing circuit includes a programmable device such as the microprocessor, microcontroller, or programmable digital signal processor described above, the processor may further include computer executable code that controls the operation of the programmable device.

[0077] The drug delivery devices described herein can be used to treat and / or prevent one or more of many different types of diseases. Exemplary diseases include, but are not limited to, rheumatoid arthritis, inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis), hypercholesterolemia, diabetes (e.g., type 2 diabetes), psoriasis, migraine, multiple sclerosis, anemia, lupus, atopic dermatitis, asthma, nasal polyps, acute hypoglycemia, obesity, anaphylaxis, and allergies. Exemplary types of drugs that may be contained in the drug delivery devices described herein include, but are not limited to, antibodies, proteins, fusion proteins, peptide bodies, polypeptides, PEGylated proteins, protein fragments, protein analogs, protein variants, protein precursors, and / or protein derivatives. Examples of drugs that may be included in the drug delivery devices described herein include, but are not limited to, the following (including non-limiting examples of related diseases in parentheses): etanercept (rheumatoid arthritis, inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis)), evolocumab (hypercholesterolemia), exenatide (type 2 diabetes), secukinumab (psoriasis), erenumab (migraine), alirocumab (rheumatoid arthritis), methotrexate (ametopterin) (rheumatoid arthritis), tocilizumab (rheumatoid arthritis), interferol β-1a (multiple sclerosis), sumatriptan (migraine), adalimumab (rheumatoid arthritis), darbepoetin alfa (anemia), belimumab (lupus), pegylated interferon β-1a' (multiple sclerosis), sarilumab (rheumatoid arthritis), semaglutide (type 2 diabetes, obesity), dupilumab (atopic dermatitis, asthma, nasal polyps, allergies), glucagon (acute hypoglycemia), epinephrine (anaphylaxis), insulin (diabetes), atropine, and vedolizumab (inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis)). Pharmaceutical formulations including, but not limited to, any of the drugs described herein, such as pharmaceutical formulations comprising the drugs listed herein (or pharmaceutically acceptable salts thereof) and pharmaceutically acceptable carriers, are also intended for use in the drug delivery devices described herein.A pharmaceutical preparation containing any of the drugs listed herein (or a pharmaceutically acceptable salt thereof) may contain one or more other active ingredients, or it may contain only one active ingredient.

[0078] The concept of the present invention has been explained primarily by reference to several examples. However, as will be readily apparent to those skilled in the art, other embodiments not disclosed above are equally possible within the scope of the concept of the present invention as defined by the appended claims.

Claims

1. A drug container enclosure (10) for housing drug containers, A designated portion (12) including a series of marks (14) for indicating the placement of the RFID label (16), An RFID label (16) attached to the designated portion (12) according to the series of marks (14), The RFID label (16) comprises a processing circuit (18) and a circuit loop (20) each having a circuit path aligned with one mark (14) of the designated portion (12), A drug container enclosure that breaks each of the circuit loops by penetrating the aforementioned mark (14).

2. The drug container enclosure according to claim 1, wherein drug information can be read from the RFID label (16), and the drug information is determined by which of the circuit loops is broken.

3. The drug container enclosure according to claim 1 or 2, wherein the RFID label (16) comprises a visual label (22) for guiding the user to the correct mark for entering the desired drug information.

4. The drug container enclosure according to claim 2 or 3, wherein the drug information includes the order in which the current drug containers are in the current dosing sequence.

5. The drug container enclosure according to claim 2 or 3, wherein the drug information includes the total number of injections to be administered in the current drug administration sequence.

6. The drug container enclosure according to any one of claims 1 to 5, wherein the mark includes a series of holes or voids in the drug container enclosure.

7. The drug container enclosure according to any one of claims 1 to 6, wherein the series of marks includes a series of vulnerable areas in the drug container enclosure.

8. The drug container enclosure according to any one of claims 1 to 7, wherein the RFID label is attached to the drug container enclosure by adhesive.

9. A drug container enclosure according to any one of claims 1 to 8, which can be attached to a drug delivery device equipped with an RFID reader.

10. A drug delivery device (1, 30) configured to accept a drug container enclosure (10) according to any one of claims 1 to 9, comprising an RFID reader (32) including a processing circuit (34), wherein the processing circuit (34) The device reads the drug information and compares the read drug information with the drug information stored on the device. A drug delivery device configured to provide the user with a display of the comparison via a user interface.

11. An RFID label (16) configured to be attached to a drug container enclosure, Processing circuit (18), The system comprises at least one circuit loop (20), the end of each circuit loop being electrically connected to the processing circuit, The circuit loop (20) is configured to be broken by an external tool for inputting drug information piercing the RFID label. An RFID label in which the processing circuit is configured to detect whether the circuit loop is complete or broken.

12. The RFID label according to claim 11, wherein the breaking of a circuit loop provides drug information to the processing circuit.

13. The RFID label according to claim 12, wherein the RFID label comprises a visual label for guiding the user to the correct position for entering the desired drug information.

14. The RFID label according to claim 13, wherein the drug information includes the order in which the current drug containers are in the current dosing sequence.

15. The RFID label according to claim 13 or 14, wherein the drug information includes the total number of injections to be administered in the current drug administration sequence.

Images